We would like to thank the authors of the Letter for their interest in our article
“Long-term prognosis of burning mouth syndrome following treatment”,
1
published in the International Journal of Oral and Maxillofacial Surgery.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to International Journal of Oral and Maxillofacial SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Long-term prognosis of burning mouth syndrome following treatment.Int J Oral Maxillofac Surg. 2022; 51: 1538-1544
- Pain relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.Int J Oral Maxillofac Surg. 2017; 46: 1501-1511
- Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbidities, treatment and outcome.J Headache Pain. 2017; 1840
- Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis.Oral Dis. 2016; 22: 503-511
- Treatment outcomes and related clinical characteristics in patients with burning mouth syndrome.Oral Dis. 2021; 27: 1507-1518
- Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults.J Am Geriatr Soc. 2019; 67: 674-694
Article info
Publication history
Published online: February 02, 2023
Accepted:
January 17,
2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
